David Farrell, PhD, Founder & Chief Scientific Officer:
Professor of Medicine in the Division of Cardiovascular Medicine, Oregon Health & Science University. 31 years in the field of blood coagulation research, 17 as a Principal Investigator. BS in Biochemistry, UCLA, PhD in Biological Sciences, Univ. of California, Irvine. Former Asst. Professor Biochemistry & Molecular Biology, Penn State University College of Medicine; former Chair, SBIR grants study section, National Institutes of Health.
David F. Eastman, MS, Chief Executive Officer:
Former CEO, Yecuris Corporation. 25 years of Life Science, biotechnology and medical device go-to-market strategies, business development, strategic relationships and venture funding with leading medical companies, i.e., Becton Dickinson, Cordis Dow Medical, Fresenius and 24 medical start-ups, MS, Marketing, Univ. of Oregon and UCLA.
Copyright © 2010, Gamma Therapeutics, Inc. All rights reserved.